Cargando…

BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer

BCL9/9L proteins enhance the transcriptional output of the β-catenin/TCF transcriptional complex and contribute critically to upholding the high WNT signaling level required for stemness maintenance in the intestinal epithelium. Here we show that a BCL9/9L-dependent gene signature derived from indep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moor, Andreas E., Anderle, Pascale, Cantù, Claudio, Rodriguez, Patrick, Wiedemann, Norbert, Baruthio, Frédérique, Deka, Jürgen, André, Sylvie, Valenta, Tomas, Moor, Matthias B., Győrffy, Balázs, Barras, David, Delorenzi, Mauro, Basler, Konrad, Aguet, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703711/ https://www.ncbi.nlm.nih.gov/pubmed/26844272 http://dx.doi.org/10.1016/j.ebiom.2015.10.030

Ejemplares similares

Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development
por: Cantù, Claudio, et al.
Publicado: (2014)

The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis
por: Vafaizadeh, Vida, et al.
Publicado: (2021)

Mutations in Bcl9 and Pygo genes cause congenital heart defects by tissue-specific perturbation of Wnt/β-catenin signaling
por: Cantù, Claudio, et al.
Publicado: (2018)

TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex
por: Zimmerli, Dario, et al.
Publicado: (2020)

Epithelial Wnt secretion drives the progression of inflammation-induced colon carcinoma in murine model
por: Degirmenci, Bahar, et al.
Publicado: (2021)

The function of BCL9 in Wnt/β-catenin signaling and colorectal cancer cells
por: de la Roche, Marc, et al.
Publicado: (2008)

Differential regulation of β-catenin-mediated transcription via N- and C-terminal co-factors governs identity of murine intestinal epithelial stem cells
por: Borrelli, Costanza, et al.
Publicado: (2021)

BCL9/BCL9L in hepatocellular carcinoma: Will it or Wnt it be the next therapeutic target?
por: Moghe, Akshata, et al.
Publicado: (2020)

Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma
por: Huge, Nicole, et al.
Publicado: (2019)

Tuning WNT-β-catenin signaling via BCL9 proteins for targeting colorectal cancer cells
por: Beaulieu, Jean-François
Publicado: (2015)

Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
por: Xu, Wei, et al.
Publicado: (2017)

GATA3 mediates nonclassical β-catenin signaling in skeletal cell fate determination and ectopic chondrogenesis
por: Maruyama, Takamitsu, et al.
Publicado: (2022)

Matrix stiffness promotes glioma cell stemness by activating BCL9L/Wnt/β-catenin signaling
por: Tao, Bei, et al.
Publicado: (2021)

Distinct adhesion-independent functions of β-catenin control stage-specific sensory neurogenesis and proliferation
por: Gay, Max Hans-Peter, et al.
Publicado: (2015)

Aristaless Related Homeobox (ARX) Interacts with β-Catenin, BCL9, and P300 to Regulate Canonical Wnt Signaling
por: Cho, Il-Taeg, et al.
Publicado: (2017)

Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating T(reg) cells
por: Feng, M., et al.
Publicado: (2019)

Wnt/β-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells
por: Kotolloshi, Roland, et al.
Publicado: (2022)

β-Catenin C-terminal signals suppress p53 and are essential for artery formation
por: Riascos-Bernal, Dario F., et al.
Publicado: (2016)

An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid
por: de la Roche, Marc, et al.
Publicado: (2012)

No Evidence of Abnormal Expression of Beta-Catenin and Bcl-2 Proteins in Pilomatricoma as One Clinical Feature of Tetrasomy 9p Syndrome
por: Charalsawadi, Chariyawan, et al.
Publicado: (2021)

Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma
por: Hyeon, Jiyeon, et al.
Publicado: (2013)

BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression
por: LING, XIAO-HUI, et al.
Publicado: (2016)

A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer
por: Tanton, Helen, et al.
Publicado: (2022)

Defining new criteria for selection of cell-based intestinal models using publicly available databases
por: Christensen, Jon, et al.
Publicado: (2012)

A novel role for the tumour suppressor Nitrilase1 modulating the Wnt/β-catenin signalling pathway
por: Mittag, Sonnhild, et al.
Publicado: (2016)

NHE9 induces chemoradiotherapy resistance in esophageal squamous cell carcinoma by upregulating the Src/Akt/β-catenin pathway and Bcl-2 expression
por: Chen, Junying, et al.
Publicado: (2015)

Modulating β-catenin/BCL9 interaction with cell-membrane-camouflaged carnosic acid to inhibit Wnt pathway and enhance tumor immune response
por: Gao, Ruqing, et al.
Publicado: (2023)

Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer
por: Gay, David M., et al.
Publicado: (2019)

Protection of Armadillo/β-Catenin by Armless, a Novel Positive Regulator of Wingless Signaling
por: Reim, Gerlinde, et al.
Publicado: (2014)

miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9
por: Yang, Chao, et al.
Publicado: (2017)

Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9
por: van Tienen, Laurens M, et al.
Publicado: (2017)

Author Correction: Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer
por: Gay, David M., et al.
Publicado: (2019)

Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes
por: Anderle, Pascale, et al.
Publicado: (2005)

WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma
por: Zimmerli, Dario, et al.
Publicado: (2018)

Type I collagen promotes tumor progression of integrin β1 positive gastric cancer through a BCL9L/β-catenin signaling pathway
por: Lv, Yalei, et al.
Publicado: (2021)

Retraction Note: miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9
por: Yang, Chao, et al.
Publicado: (2023)

Activation of Bcl-2-Caspase-9 Apoptosis Pathway in the Testis of Asthmatic Mice
por: Xu, Wenyuan, et al.
Publicado: (2016)

Correction: Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9
por: van Tienen, Laurens M, et al.
Publicado: (2017)

KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer
por: Yao, Hanhui, et al.
Publicado: (2022)

miR-766-3p Targeting BCL9L Suppressed Tumorigenesis, Epithelial-Mesenchymal Transition, and Metastasis Through the β-Catenin Signaling Pathway in Osteosarcoma Cells
por: Zhang, Sheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p76aeh2v50o4ulh3d4cegbbn04